Molecular basis of an autoantibody-associated restriction fragment length polymorphism that confers susceptibility to autoimmune diseases

Keyphrases

• Autoimmune Disease 100%
• Restriction Fragment Length Polymorphism 100%
• Autoantibodies 100%
• Immune System 66%
• V Genes 66%
• Genotype 33%
• Rheumatoid Factor 33%
• Rheumatoid Arthritis 33%
• Heavy Chain 33%
• Polymorphism 33%
• Systemic Lupus Erythematosus 33%
• Genetic Basis 33%
• Gene Repertoire 33%
• Homozygous Deletion 33%
• Molecular Study 33%
• Normal Function 33%
• B Cell Repertoire 33%
• Homologous Genes 33%
• Immune-compromised Patients 33%
• Serosurvey 33%
• Autoreactive 33%
• EcoR1 33%

Immunology and Microbiology

• Autoimmune Disease 100%
• Restriction Fragment Length Polymorphism 100%
• Autoantibodies 100%
• Immune System 66%
• Polymerase Chain Reaction 33%
• Rheumatoid Factor 33%
• Inflammatory Arthritis 33%
• Heavy Chain 33%
• Monospecific Antibody 33%
• Normal Human 33%
• Intravenous Immunoglobulin 33%
• Systemic Lupus Erythematosus 33%
• B Cell 33%

Biochemistry, Genetics and Molecular Biology

• Autoantibodies 100%
• Rheumatoid Factor 33%